Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001555280-25-000261
Filing Date
2025-08-05
Accepted
2025-08-05 13:58:00
Documents
94
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zts-20250630.htm   iXBRL 10-Q 2306844
2 EX-10.1 zoetis-executiveseverancep.htm EX-10.1 122250
3 EX-31.1 a10qex311q22025.htm EX-31.1 8839
4 EX-31.2 a10qex312q22025.htm EX-31.2 8949
5 EX-32.1 a10qex321q22025.htm EX-32.1 4109
6 EX-32.2 a10qex322q22025.htm EX-32.2 4084
  Complete submission text file 0001555280-25-000261.txt   10634941

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zts-20250630.xsd EX-101.SCH 54571
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zts-20250630_cal.xml EX-101.CAL 79126
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zts-20250630_def.xml EX-101.DEF 310715
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zts-20250630_lab.xml EX-101.LAB 710382
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zts-20250630_pre.xml EX-101.PRE 544223
96 EXTRACTED XBRL INSTANCE DOCUMENT zts-20250630_htm.xml XML 1822160
Mailing Address 10 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 10 SYLVAN WAY PARSIPPANY NJ 07054 973-822-7000
Zoetis Inc. (Filer) CIK: 0001555280 (see all company filings)

EIN.: 460696167 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35797 | Film No.: 251184182
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)